Instagram and Podcast Intervention for Breast Cancer Awareness and Screening
The Effect of an Instagram- and Podcast-Based Intervention on Women's Breast Cancer Awareness, Health Beliefs, and Screening Behaviors: A Randomized Controlled Trial
Visão geral do estudo
Status
Condições
Descrição detalhada
Breast cancer is the most frequently diagnosed cancer among women worldwide and remains a major public health concern. Early detection through screening is essential for reducing breast cancer-related morbidity and mortality. However, many women continue to experience barriers to screening participation, including limited awareness, insufficient knowledge, low perceived susceptibility, fear of diagnosis, and inadequate health beliefs regarding breast cancer and its screening methods.
Digital health interventions have emerged as accessible and cost-effective approaches for delivering health education and promoting preventive health behaviors. Social media platforms, particularly Instagram, are widely used by young women and offer an effective channel for disseminating health-related information. Podcasts provide an additional narrative-based educational approach that may enhance engagement, improve information retention, and support behavior change through emotionally meaningful content.
This randomized controlled trial aims to evaluate the effectiveness of an Instagram- and podcast-based intervention in improving breast cancer awareness, health beliefs, and screening behaviors among women aged 20-39 years. Participants in the intervention group will receive evidence-based educational content through Instagram posts and podcasts, while the control group will receive no intervention during the study period. Outcomes will include breast cancer awareness, health beliefs related to breast cancer screening, and screening behaviors such as breast self-examination practices.
The findings of this study are expected to provide evidence regarding the effectiveness of combined social media and podcast-based interventions as scalable, low-cost strategies for promoting breast cancer awareness and encouraging preventive screening behaviors among women.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Baise BİCAV
- Número de telefone: 0 312 329 10 10
- E-mail: baisebicav@gmail.com
Estude backup de contato
- Nome: Zehra BİCAV
- Número de telefone: 0 312 329 10 10
Locais de estudo
-
-
-
Ankara, Turquia (Türkiye)
- Recrutamento
- Ankara
-
Contato:
- Baise Bicav
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Women aged 20-39 years
- Able to read and write Turkish
- Turkish citizens
- Have an active Instagram account and access it at least once daily
- No previous diagnosis of cancer
- Willing to participate and provide informed consent
Exclusion Criteria:
- No access to a smartphone with the Instagram application
- Visual, hearing, or cognitive impairment that may prevent participation in the intervention
Withdrawal Criteria:
- Failure to complete the assigned podcast sessions during the intervention period
- Participant request to withdraw from the study at any time
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Triagem
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Instagram Group
Participants will receive an 8-week Instagram-based breast cancer awareness intervention.
|
Participants will follow the "Breast Health Academy" Instagram account and receive an 8-week Instagram-based breast cancer awareness intervention.
Educational breast cancer awareness and screening content will be shared as posts and stories on Mondays, Wednesdays, and Saturdays.
Reminder stories encouraging breast self-examination (BSE), such as "Do not forget to perform your monthly BSE" and "Remember to perform BSE this week," will be shared on Tuesdays, Thursdays, and Sundays.
Stories will also be saved as highlights.
No content will be shared on Fridays, and all posts and stories will be published at the same time each day.
|
|
Experimental: Instagram + Podcast Group
Participants will receive an 8-week Instagram- and podcast-based breast cancer awareness intervention.
|
Participants will follow the "Breast Health Academy Plus" Instagram account and receive an 8-week Instagram- and podcast-based breast cancer awareness intervention.
Educational breast cancer awareness and screening content will be shared as posts and stories on Mondays, Wednesdays, and Saturdays.
Reminder stories encouraging breast self-examination (BSE) will be shared on Tuesdays, Thursdays, and Sundays and saved as highlights.
In addition, one educational podcast episode developed for the intervention will be delivered weekly via Instagram direct message every Friday.
All content will be provided at the same time each day throughout the intervention period.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Breast Cancer Awareness Scale
Prazo: Assessments will be performed at baseline and Week 8.
|
The Breast Cancer Awareness Measure assesses awareness of breast cancer symptoms, breast self-examination practices, and age-related risk perception.
Total scores range from 0 to 3, with higher scores indicating greater breast cancer awareness.
|
Assessments will be performed at baseline and Week 8.
|
|
Champion's Health Belief Model Scale in Breast Cancer Screening
Prazo: Assessments will be performed at baseline and Week 8.
|
The Champion's Health Belief Model Scale (CHBMS) for Breast Cancer Screening is a validated instrument used to assess health beliefs related to breast cancer screening.
The Turkish version consists of six subscales: perceived susceptibility (3 items), perceived seriousness (6 items), health motivation (5 items), perceived benefits of breast self-examination (BSE) (4 items), perceived barriers to BSE (8 items), and BSE self-efficacy/confidence (10 items).
Each subscale is evaluated separately, and no total score is calculated.
Higher scores on the perceived susceptibility, perceived seriousness, health motivation, BSE benefits, and BSE self-efficacy/confidence subscales indicate stronger health beliefs, whereas higher scores on the BSE barriers subscale indicate greater perceived barriers to breast cancer screening and breast self-examination.
|
Assessments will be performed at baseline and Week 8.
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Participant Satisfaction (VAS)
Prazo: Assessed at Week 8.
|
Participant satisfaction with the Instagram- and podcast-based intervention will be assessed using a 0-10 Visual Analog Scale (VAS), where 0 indicates "not satisfied at all" and 10 indicates "extremely satisfied."
|
Assessed at Week 8.
|
|
Breast Cancer Screening Behavior Questionnaire
Prazo: Assessments will be performed at baseline and Week 8.
|
Breast Cancer Screening Behavior Questionnaire.
A researcher-developed 3-item questionnaire assessing breast cancer screening behaviors, including breast self-examination within the previous month, clinical breast examination by a healthcare professional, and mammography uptake or scheduling.
Each item is recorded as Yes or No and analyzed separately.
No total score is calculated; therefore, minimum and maximum scores are not applicable.
|
Assessments will be performed at baseline and Week 8.
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Baise Bicav, Yuksek Ihtisas University
- Investigador principal: Zehra Bicav, Yuksek Ihtisas University
- Diretor de estudo: Sevinç Kutlutürkan, Ankara University
- Diretor de estudo: Filiz Ünal Toprak, Saglik Bilimleri Universitesi
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- AU-HEM-BB-02
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .